Abstract
Treatment readiness is a key predictor of drug treatment completion, rearrest, and recidivism during community reentry; however, limited data exist among homeless female offenders (HFOs). The purpose of this study was to present baseline data from a randomized controlled trial of 130 HFOs who had been released from jail or prison. Over half (60.8%) of HFOs had a treatment readiness score of ≥40 (n = 79, mean [μ] = 40.2, SD = 8.72). Bivariate analyses revealed that methamphetamine use, psychological well-being, and high emotional support were positively associated with treatment readiness. On the contrary, depressive symptomatology and depression/anxiety scores were negatively associated with the treatment readiness score. Multiple linear regression revealed that depressive symptomatology was negatively associated with treatment readiness (β = −0.377, p = .001). Further analyses revealed that the effect of emotional support on treatment readiness was mediated by depressive symptomatology.
Introduction
In the past decade, there has been an increasing number of female offenders in the U.S. Criminal Justice System (Ahmed, Angel, Martell, Pyne, & Keenan, 2016). In total, nearly 6.7 million adults are under correctional supervision and over 1.25 million are women (Kaeble & Glaze, 2016). Female offenders with a history of homelessness are at high risk for drug use and relapse (A. M. Nyamathi, Srivastava, et al., 2016), which can lead to ongoing arrests, convictions, and incarceration.
Treatment readiness is a multidimensional concept encompassing both internal (person) and external (context) elements (Ward, Day, Howells, & Birgden, 2004). To increase the likelihood of successful treatment completion, individuals need to be treatment ready, motivated, and engaged with the treatment program components. The importance of treatment readiness cannot be underestimated; for many professionals working with criminal justice-involved women, it is challenging to work with those who lack motivation, are nonadherent, or are treatment-resistant (Wong, Gordon, & Gu, 2007).
Being able to define and operationalize treatment readiness can help to focus and inform academicians and providers on areas of need to mitigate recidivism. However, there is a lack of consensus regarding measuring treatment readiness due to the lack of a solid theoretical model and the fact that models focus on different key constructs which ultimately influence the measurement.
Application of Comprehensive Health Seeking and Coping Paradigm (CHSCP) to Treatment Readiness Among Formerly Incarcerated, Homeless Women During Reentry
Treatment readiness among formerly incarcerated, homeless women during reentry is not well understood and will be explored using an empirically tested model known as the CHSCP (A. Nyamathi, 1989). Developed nearly 25 years ago, the CHSCP model (A. Nyamathi, 1989) is based on the Lazarus Schema of Coping and Adaptation (Lazarus & Folkman, 1984) and the Schlotfeldt Health Seeking and Coping Paradigm (Schlotfeldt, 1981). The CHSCP has been well-utilized by the authors for decades and has been tested with homeless populations who have participated in intervention programs designed to enhance hepatitis A and B virus vaccination treatment compliance (A. Nyamathi et al., 2015) and reduce drug and alcohol use (A. M. Nyamathi, Zhang, et al., 2016).
Based on the CHSCP, a number of factors may be considered as they impact treatment readiness. In particular, these include sociodemographic, social, behavioral, and psychological factors. Sociodemographic factors included age, race/ethnicity, education, and history of incarceration. Social factors encompassed social support from family, friends, and health care professionals, all of which may provide encouragement for treatment continuation (Litt, Kadden, Tennen, & Kabela-Cormier, 2016), as well as empathy and strengthening positive coping strategies (Fitzpatrick, 2016). Behavioral and psychological factors included mental health status and substance use. These factors are proposed to impact treatment readiness.
Other theoretical models and frameworks that relate to treatment readiness include the Transtheoretical Stages of Behavior Change (TTM; Prochaska & DiClemente, 1982) and the Multifactor Offender Readiness Model (MORM; Mossière & Serin, 2014). While the TTM benefits include its stepwise change model, change does not occur in a linear process and may not be flexible to change (Drieschner, Lammers, & van der Staak, 2004). The MORM is another framework which came later and may be helpful in understanding key conditions for treatment engagement readiness, as they include both the internal (i.e., cognitive, affective, volitional, behavioral, and identity) and external (i.e., circumstances, location, opportunity, resources, support, program, and timing) readiness conditions that may influence program engagement, participation, and subsequent attrition.
The CHSCP, a multidimensional framework, has some similarities with these models in that they broadly consider factors which influence behavior change which may include internal components and health goals of the client. However, key difference between the CHSCP as compared with other models is that nursing goals and strategies are integrated to improve immediate and long-term health outcomes.
Challenges Experienced by Justice-Involved Women During Reentry
Justice-involved women face a number of individual-level, program-level, and systems-level challenges during reentry. Prior to this current exploratory analysis, formative work utilized qualitative methods to understand challenges women experienced during reentry (Salem, Nyamathi, Idemundia, Slaughter, & Ames, 2013). Formerly incarcerated, homeless women shared health care challenges, knowledge deficits, and barriers in moving forward in life. Health care challenges included inability to obtain mental and oral health care, and women’s health care including prenatal care and sexually transmitted infection (STI) testing (i.e., chlamydia and HIV). Women also shared the difficulties related to not being able to find gainful employment due to having a felony record (Salem et al., 2013).
Building upon this study, another qualitative study was conducted to understand perspectives of formerly incarcerated, homeless women residing in a residential drug treatment (RDT) program (A. M. Nyamathi, Srivastava, et al., 2016). These women shared several factors associated with first drug use which included curiosity, negative life circumstances, and personal choices. Relatedly, some factors involved in reported relapse included desire to numb pain and challenging life experiences; other women discussed the lack of resources (A. M. Nyamathi, Srivastava, et al., 2016). Informed by previous research, the current study delves deeper into challenges experienced by formerly incarcerated, homeless women during reentry, and how these factors influence treatment readiness and contribute to recidivism.
Contributing Factors Associated With Treatment Readiness
Both intrinsic and extrinsic factors may predict successful outcomes in substance abuse treatment adherence and retention (Burlew, Montgomery, Kosinski, & Forcehimes, 2013). For women who successfully enter RDT, lack of treatment readiness may negate any benefits of receiving drug treatment or result in early departure from RDT or outpatient drug treatment program. Readiness to make changes in one’s life after experiencing incarceration or drug treatment is closely related to treatment readiness. Among male and female probationers with substance use problems, those who showed a higher tendency to attend drug treatment sessions were African Americans and Latinos, were older, had lived primarily in an institution in the past 30 days, and were unemployed (Roque & Lurigio, 2009). In the CHSCP model, these individual-level variables such as race/ethnicity and age are taken into account.
In a young population of drug users, characteristics associated with readiness to change included self-efficacy, problem recognition, realistic understanding of the negative consequences of drug use, and motivation to achieve promising goals (Becan, Knight, Crawley, Joe, & Flynn, 2015; Carroll, Ashman, Bower, & Hemingway, 2013). For homeless women in particular, participating in a 12-step substance use program, and having experienced negative sequelae of using substances, was a significant motivator to reduce substance use (Upshur et al., 2014). Among individuals going through outpatient alcohol and drug treatment, greater attendance in group sessions was correlated with higher readiness to change (Zemore, 2012). In the CHSCP model, drug and alcohol use along with treatment readiness are applied.
Although research that directly identifies factors that contribute to treatment readiness in female offenders is severely lacking, it is thought that gender differences in treatment program completion may stem from gender norms (Fiorentine, Anglin, Gil-Rivas, & Taylor, 1997). More specifically, these authors explain the reason women in RDT participate more in group sessions as compared with their male counterparts may be based on gender preferences for greater help-seeking, strength, and control than men in drug treatment.
For women, predictors of failure to complete substance use treatment include having a low employment score and a drug dependence diagnosis, while predictors for men included having psychiatric diagnoses, being a Medicaid recipient, and why they entered treatment (Green, Polen, Dickinson, Lynch, & Bennett, 2002). In another study, women with lower self-esteem and poor coping strategies, and those who lacked social and financial support and access to services experienced more challenges with recovery from drugs (Yang et al., 2015) than did those without these characteristics. In the CHSCP model, self-esteem, social support, and coping are considered as variables that might impact outcomes.
Psychological factors that may affect treatment readiness include depression. An association exists in the literature among depression and hopelessness (Hendriks et al., 2014) and avoidance behaviors (Moulds, Kandris, Starr, & Wong, 2007; Ottenbreit, Dobson, & Quigley, 2014). Conversely, decrease in drug use may also be associated with decrease in depression (Jaffe, Shoptaw, Stein, Reback, & Rotheram-Fuller, 2007).
Finally, another important concept to consider is self-efficacy, defined as the belief in the ability to make desired changes (Bandura, 1977; Kadden & Litt, 2011) which is a related, but distinct concept from treatment readiness. Self-efficacy may be positively related to treatment readiness and can affect substance use and recidivism. In particular, self-efficacy has been shown to predict alcohol and drugs consumption (Kadden & Litt, 2011).
Purpose
Given the relationship between treatment readiness prior to program entrance and dropout, it is important to assess formerly incarcerated homeless women’s treatment readiness and its impact on drug and alcohol abstinence. Few investigators have assessed treatment readiness within this vulnerable population. Therefore, the purpose of this study is to assess correlates of treatment readiness among formerly incarcerated, homeless women to integrate these findings into a future intervention.
Method
Sampling Procedure
This cross-sectional study was an analysis of baseline data from a clinical trial in which 130 homeless female offenders (HFOs) were randomized into one of two behavioral interventions. Participants were recruited from four community-based sites in Los Angeles and Pomona, California. Three were RDT facilities and one was a homeless drop-in site. The RDT facilities were structured therapeutic communities which focused on reducing substance use and preparing residents for reentry. The residents generally stayed up to 6 months and many voluntarily selected the RDT than a longer period of incarceration. The three homeless facilities were focused on addressing basic needs for homeless women and offered services that included meals, showers, social services, and case management.
Eligible women included those who (a) were 18 to 65 years of age, (b) were homeless when released from jails or prisons, and (c) had a history of drug or alcohol use. Exclusion criteria included (a) speaking languages other than English or (b) exhibiting active psychotic symptoms. Baseline data were collected from February 2015 to May 2016. The majority of the women from the drug treatment programs had been enrolled in the drug treatment programs for the 2 to 3 months before data collection was conducted. Study participation was completely voluntary. In total, 176 HFOs were screened; 46 were ineligible based on screening criteria of age, history of drug use, or time since paroled; and one participant’s data were not usable. The total sample was 130 participants. The study was approved by the University of California, Los Angeles (UCLA) Institutional Human Subjects Protection Committee.
Participant Characteristics
Table 1 depicts the baseline characteristics of the 130 HFOs. The mean age was 38.9 (SD = 11.4) years. The majority were Black or Latino (80.8%), 70.0% had 12 years or higher levels of education, and the majority (83.1%) were unemployed. Over half (54.6%) of participants were incarcerated in prison (vs. jail only). Over a quarter (26.8%) were incarcerated in jail or prison 5 or more times. The mean score for treatment readiness was 40.24 (SD = 8.72) and over half (60.8%) of HFOs scored ≥40 (n = 79, μ = 40.2, SD = 8.72).
Sociodemographic Characteristics of Sample (N = 130)
Note. GED = General Educational Development.
Table 2 depicts self-reported substance use. The most commonly reported substances used during the 6 months prior to the interview were alcohol (41.5%), marijuana (36.2%), and methamphetamine (31.5%). Less than a quarter (20.8%) reported previous 6-month history of crack and cocaine use (17.7%), respectively.
Behavioral, Social, and Emotional Factors of Sample (N = 130)
Note. MHI = Mental Health Index; CES-D = Center for Epidemiological Studies Depression.
Study Procedures
Potential participants were informed of the study by approved posted flyers. After weekly informational sessions were delivered by the trained research staff, interested persons met individually with the research staff to receive detailed information about the study in a private location. Written informed consent was obtained for interested residents to allow screening for eligibility by means of a 2-min survey. Among those eligible, a second informed consent was provided, followed by the administration of a 45-min baseline questionnaire. Participants were offered short breaks during the questionnaire administration to reduce respondent fatigue. Research staff who recruited participants and administered questionnaires were not involved in providing the intervention. Remuneration was provided in the amount of US$18 for the initial screening and the baseline survey.
Based on responses to the questionnaire, participants were randomized into one of two groups (i.e., the dialectical behavioral therapy [DBT] or health promotion [HP] program). A computer program performed URN Randomization to balance participant characteristics (e.g., age, risk of recidivism) which were expected to influence outcomes of the two programs. Based on group assignment, participants were provided a Part 2 informed consent for either program. Thereafter, informed consent was obtained and participants were given an appointment for a starting period which continued over a 6-week period. Participants randomized to either program were assigned a peer coach and asked to meet once a week for up to 6 weeks.
The DBT program group sessions were 45 min and provided by a nurse and peer coach. Participants were also invited to meet one-on-one with the nurse or peer coach for 20 min to discuss content related to the group program. Participants assigned to the HP group attended up to 20-min group sessions over a 6-week period provided by a separate nurse or project coordinator. The HP participants also met one-on-one with a research staff nurse or project coordinator for up to 20 min.
Measures
Guided by the CHSCP, variables were selected which were hypothesized to influence treatment readiness. Sociodemographic questions elicited information on age, race/ethnicity, employment, and education status in the 6 months before the most recent incarceration. Incarceration history was assessed based on being on parole or probation, number of times in prison or jail, and time in months since last incarceration.
Independent Variables
Substance use was measured within the last 6 months prior to the last incarceration using the Texas Christian University (TCU) Drug History form (TCU, Institute of Behavioral Research, 2007). Drug use responses were coded as “yes” or “no” as to whether the respondent reported use of marijuana, crack, methamphetamine, amphetamine, and tranquilizers. Next, alcohol use within the last 6 months prior to their last incarceration was assessed using the TCU Drug History form (TCU, Institute of Behavioral Research, 2007). Any alcohol use was assessed using “yes” or “no” response.
Depressive symptoms were assessed using a 10-item Center for Epidemiological Studies Depression (CES-D) scale, short version (Andresen, Malmgren, Carter, & Patrick, 1994). This scale measured the frequency of depressive symptoms in the past week on a 4-point response scale from “rarely or none of the time (less than 1 day),” “some of the time (3-4 days),” “occasionally or a moderate amount of the time (3-4 days),” to “most of the time (5-7 days)” and were scored from 0 to 3, respectively. Scores were summed and ranged from 0 to 30 with two items in the scale being reverse coded. A score of 10 or greater was considered to reflect depressive symptomatology. In this study sample, depressive symptomatology had an internal consistency reliability coefficient of .82.
Social support was assessed using four subscales from the 19-item Medical Outcomes Study (MOS) Social Support Survey which assessed Emotional/Informational Support (eight items, α = .96), Tangible Support (four items, α = .92), Positive Support (three items, α = .94), and Affectionate Support (three items, α = .91; Sherbourne & Stewart, 1991). Items had a 5-point Likert-type scale response options ranging from “none of the time” to “all of the time.” A higher score indicates more support.
Mental Health Index (MHI) was assessed using a five-item index (Stewart, Hays, & Ware, 1988). This index measured depression, anxiety, and psychologic well-being during the past month. Responses were scored on a 6-point scale from “all of the time” to “none of the time” with numeric score ranging from 1 to 6, respectively. A sample question included “How often, during the past month, have you felt so down in the dumps that nothing could cheer you up?” In this study, the Cronbach’s α was .87. Item scores were summed after reverse coding the score on some of the questions and then linearly transformed to a 0 to 100 range, with higher values indicating better emotional well-being.
Dependent Variable
Treatment readiness was assessed using a eight-item TCU CJ Client Evaluation of Self and Treatment (CJ CEST), using a 5-point Likert-type scale, which measured current treatment readiness (TCU, Institute of Behavioral Research, 2005; Joe, Broome, Rowan-Szal, & Simpson, 2002). A sample item included “This treatment program can really help you.” Treatment readiness has an internal consistency reliability coefficient of .75 (Joe et al., 2002). Answers to items were averaged and then multiplied by 10. Scores ranged from 10 to 50, with scores above 30 (higher score indicating stronger agreement) and those below 30 indicative of stronger treatment readiness disagreement. In this sample, treatment readiness had an internal consistency reliability coefficient of .80.
Data Analysis
Bivariate associations between participant characteristics and the treatment readiness score were assessed using one-way ANOVA for categorical variables and the Pearson’s correlation coefficient for continuous variables. Multiple linear regression models were fitted with treatment readiness score as the dependent variable. Independent variables were selected based on our theoretical framework, regardless of bivariate correlations, including variables for mental health, drug use, and social support. The base model included age, race/ethnicity, and time since last exit from jail or prison as independent variables. Employment status was not considered for inclusion in the model as very few of our participants were employed.
Constructs corresponding to mental health (Depressive Symptomatology and MHI), drug use, and social support were sequentially added to the base model. Linearity and homoscedasticity assumptions were assessed by visually examining plots of model residuals versus predicted values. Normal quantile plots were used to assess normality of the residuals. Three observations from the final model were identified as influential observations based on Cook’s distance estimates. Removing these observations did not change the conclusions, and thus, they were retained in the analysis dataset.
Results
Bivariate Analyses
Table 3 depicts bivariate analysis of factors associated with treatment readiness scores. Significant correlates of treatment readiness score were emotional support (p = .049) and mental health (p = .027). A significant, negative relationship was found between treatment readiness and depressive symptomatology (p = .001).
Factors Associated With Treatment Readiness Score in Bivariate Analysis (N = 130)
Note. GED = General Educational Development; MOS = Medical Outcomes Study.
Multiple Linear Regression
Table 4 depicts results of multiple linear regression analysis. In Model 1 (base model), no evidence of correlation was found between treatment readiness and age, racial/ethnic categories, or time since last exit from jail or prison. Mental health and depressive symptomatology were initially considered for Model 2, but due to high levels of multicollinearity between these two variables (Pearson’s r = –.663), MHI was dropped from the model. A statistically significant negative correlation was found between treatment readiness and depressive symptomatology when added to Model 1 (β = 0.373, p = .002; Model 2). Depressive symptomatology remained negatively correlated with treatment readiness after controlling for any drug use (Model 3) and any drug use and emotional support (Model 4).
Multiple Linear Regression of Treatment Readiness (N = 130)
No independent correlation was found between treatment readiness and any drug use or emotional support after controlling for depressive symptomatology. Inserting variables for the use of each specific drug into the model instead of the composite “any drug use” variable did not change our findings.
Mediational Analysis
In post hoc analysis, we tested the hypothesis that social support may be associated with reduced depressive symptomatology and indirectly affect treatment readiness. We therefore performed mediation analysis to explore the indirect effect of emotional support on treatment readiness through depressive symptomatology (i.e., emotional support increases treatment readiness by reducing depression). Mediation analysis demonstrated that (a) emotional support score was associated with a decrease in depressive symptomatology (β = −1.440, p = .004); (b) emotional support score was associated with an increase in the treatment readiness score (β = 1.351, p = .049); and (c) depressive symptomatology remained negatively associated with the treatment readiness score (β = −0.339, p = .005) in the regression model after controlling for the emotional support score (β = 0.862, p = .209; Baron & Kenny, 1986). The reduced β for the emotional support score in Model 3 suggested that 36% of the total effect of the emotional support score on the treatment readiness score was through an indirect effect by depressive symptomatology.
Discussion
This cross-sectional study found a relatively high level of treatment readiness among HFOs exiting jails and prisons, many of whom were enrolled in a RDT program. Our findings revealed that the treatment readiness score was high in our population and that depressive symptomatology was significantly negatively correlated with treatment readiness. In the bivariate model, factors associated with treatment readiness were methamphetamine use, psychological well-being, and emotional support. These factors were further supported by the CHSCP guiding the study (A. Nyamathi, 1989). Insight gained from our data can assist in the formulation of theoretically guided treatment approaches aimed at addressing the psychosocial challenges experienced by HFOs. Such tailored approaches may be tested for impact on increasing this especially vulnerable group’s readiness to commit to substance abuse treatment.
The finding that depressive symptomatology was independently associated with treatment readiness is noteworthy as half of all participants reported scores of high levels of depressive symptomatology. This finding is also consistent with the theoretical premise and literature demonstrating a higher prevalence of depression among both homeless individuals (Lebrun-Harris et al., 2013; Strehlau, Torchalla, Kathy, Schuetz, & Krausz, 2012) and female parolees (Bloom & Covington, 2008). Substandard living conditions, as well as resource scarcity associated with homelessness, may make HFOs more susceptible to depression than their housed counterparts. However, more research is needed to examine housing support interventions that may begin shortly after HFOs enter their communities. In fact, there is a critical need for mental health screening, treatment, and referral into care to increase treatment readiness in this population during reentry.
The proclivity of depressed persons to avoid fearful and/or challenging situations, such as getting off drugs, may potentially contribute to low treatment readiness. Furthermore, for homeless women who have had a recent history of incarceration, being faced with many barriers to improving their life may further promote a feeling of hopelessness and use of avoidant behaviors.
Our mediation analysis revealed that depression secondary to poor emotional support was negatively associated with treatment readiness. Unstable residence, inconsistent means of communication, higher prevalence of trauma, and family discordance and separation among the homeless (Narayan et al., 2016) and incarcerated (Messina & Grella, 2006), may contribute to perceived low emotional support, subsequent depressive symptomatology, and lack of readiness to fully engage in treatment.
In our study, high emotional support scores revealed a strong correlation with treatment readiness. This is consistent with findings among a community sample (N = 193) comprised primarily of women with elevated depressive symptoms, in which fewer and less satisfying social supports correlated strongly with higher avoidance and rumination, as well as greater social and work/school impairment (Kanter, Rusch, Busch, & Sedivy, 2009). Social support is often lacking in the lives of HFOs who experience ostracism from their communities and whose familial relationships are often conflict-ridden. Future interventions should consider methods of bolstering emotional support and reducing depression for HFOs to enhance readiness to commit to drug treatment programs.
In bivariate analysis, high scores on psychological well-being were correlated with treatment readiness. Mental illness poses a particular challenge to readiness for and pursuit of behavioral changes. Mental illness disorders characterized by lack of insight and poor reality testing may disrupt one’s cognitive abilities to identify a need for change, conceptualize strategies for effecting change, and sustain change-making behaviors. For HFOs with mental illness, managing symptoms may take precedence over or need to be co-occurring with drug treatment. Alternatively, as substance abuse may ameliorate the distress of mental illness, thus compromising treatment readiness, immediate screening and treatment is critical as the women enter drug treatment programs.
Drug treatment programs targeted to female offenders have demonstrated effectiveness in reducing substance use (Hall, Prendergast, Wellisch, Patten, & Cao, 2004; Pelissier et al., 2001; Sacks, McKendrick, & Hamilton, 2012). However, when there is a lack of readiness, HFOs may compromise their chances of remission and recovery. Substance use is a public health epidemic, with profound social, economic, and health consequences for individuals and society at large (Degenhardt & Hall, 2012). Our findings highlight the fact that simply improving access to RDT programs is likely insufficient, and that enhancing treatment readiness may better equip this population with a greater chance of recovery.
We also found a negative association between depression and treatment readiness among HFOs. Based on our findings, focused interventions to address depressive symptoms with further assessment and screening may improve treatment success. Furthermore, it is possible that the discontinuity of treatment between institutions and reentry may influence mental health seeking (Wang et al., 2010). One solution-oriented approach is to initiate a transitions clinic (Wang et al., 2010) which can help address depressive symptoms utilizing mindfulness-based, cognitive-behavioral therapy (MBCBT; Chiesa, Mandelli, & Serretti, 2012; Shawyer, Enticott, Ozmen, Inder, & Meadows, 2016; Teasdale et al., 2000). However, depressive symptoms need to be understood within the cultural and ethnic lens of this population. Formative work is needed to fully understand the viewpoints of depression and strategies to deal with depression, establishing linkage into care, and improve emotional support which could ultimately improve treatment success and community reentry.
Study Limitations
Several limitations are important to discuss which include the following: first, our cross-sectional study design precludes causal inferences between dependent and independent variables; however, it seems more likely that depression affects treatment readiness than the reverse. Second, the results of the meditational analysis should be interpreted cautiously given the cross-sectional study design. Third, the possible attenuation of correlation due to scaling is important to mention. Likewise, while our findings are suggestive of mediation, longitudinal studies are needed to elucidate this relationship. In addition, this sample is focused solely on homeless women involved in the criminal justice system; thus, this focus may result in distinct social and occupational barriers compared with male offenders or female nonoffending counterparts. Last, the small sample size and focus on western United States may further limit the generalizability of our data to other populations.
Conclusion
In conclusion, we found a negative association between depression and treatment readiness among HFOs. Based on our findings, focused interventions to address depressive symptoms with further assessment and screening may improve treatment success. Furthermore, it is possible that the discontinuity of treatment between institutions and reentry may influence mental health seeking (Wang et al., 2010). One solution-oriented approach is to initiate a transitions clinic (Wang et al., 2010) which can help address depressive symptoms utilizing MBCBT (Chiesa et al., 2012; Shawyer et al., 2016; Teasdale et al., 2000). However, depressive symptoms need to be understood within the cultural and ethnic lens of this population. Formative work is needed to fully understand the viewpoints of depression and strategies to deal with depression, establishing linkage into care, and improve emotional support which could ultimately improve treatment success and community reentry. Insight gained from our data can assist in the formulation of tailored and targeted treatment approaches aimed at addressing the psychosocial challenges experienced by HFOs.
Footnotes
This study is supported by the National Institute on Drug Abuse (NIDA) through Grant R34DA035409, NIAID through Grant K01AI118559, and the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), through Grant UL1TR001881.
